JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure
|
|
|
- Oscar Shepherd
- 8 years ago
- Views:
Transcription
1 JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure Kelly L. Close, president, Close Concerns editor-in-chief, diatribe March 1, 2014 closeconcerns.com Slide 1
2 We thank many researchers, scientists + funders
3 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVA s overnight closed-loop system The future of diabetes technology Slide 3
4 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas MGH / BU UVA s overnight closed-loop system The future of diabetes technology
5 About Us Close Concerns: founded in 2002 as a healthcare information company focused exclusively on diabetes Our mission: to improve patient outcomes by making everyone smarter about diabetes and obesity Providing a platform for young healthcare leaders is also incredibly important to us.
6
7 About Us diatribe: founded in 2006, a website for patient education. Our mission is to help people with diabetes become healthier and happier through education. diatribe is a non-profit supported by the Helmsley Charitable Trust and many others. Over 100,000 readers have visited the diatribe website over the last 18 months (
8 Slide 8
9 About Us dq&a dq&a: founded in 2009, a market research company focused on diabetes and obesity. The mission is to help the diabetes industry understand the true voice of the patient and their healthcare team. dq&a works with a panel of 12,000 patients, interviewing them quarterly (now for 18 straight quarters). Also works with panels of educators and physicians, and provides custom research.
10 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
11 Living with diabetes can and should provide you with the opportunity to celebrate a full, active, and wonderful life. The tools and resources available for you to care for your diabetes in the midst of a busy, productive and fulfilling life are better today than at any time in the modern history of diabetes care. -Dr. David Kendall, Eli Lilly, Indianapolis, IN
12 A1c necessary but not sufficient A seven-center, 21-day CGM study found that: People with type 1 diabetes were found to be in the optimal ADA glycemic zone only 28% of the time, on average spending over 2 hours/day in hypoglycemia Source: Dr. Bruce Bode, Diabetes Care, 2005 Glycemic Characteristics in Continuously Monitored Patients with Type 1 and Type 2 Diabetes
13 Why A1c does not tell the full story... An A1c of 7% = average of 154 mg/dl Range Example 1 < 70 mg/dl 8% mg/dl 63% > 180 mg/dl 29% Approximate A1c 7.0% Example 2 24% 18% 58% 7.0% Example 3-100% - 7.0% But time in range and thus quality of A1c can be drastically different! Source: the diatribe Foundation
14 Example 1 A1c of 7%
15 Example 2 A1c of 7%
16 Example 3 A1c of 7%
17 Medtronic MiniMed 530G (Enlite/Veo) FDA approved in late September 2013
18 Insulet s New OmniPod Launched in % smaller, 16% slimmer vs. old OmniPod New LifeScan Verio BGM handheld just submitted to FDA Working on combined pod/cgm integration
19 Telcare cellular-enabled blood glucose meter Wireless blood glucose monitor that automatically uploads results online Source: Close Concerns, Inc.
20 LifeScan OneTouch Verio Sync App and meter just launched in January. Wireless (Bluetooth) Source: Close Concerns, Inc.
21 Glooko MeterSync Cable/Web Platform Available for iphone and Android; compatible with 29 meters Working on Bluetooth version Source: Close Concerns, Inc.
22 Dexcom Share (remote monitoring) Under FDA review; potential 2014 launch Wireless Dexcom G4 Receiver + Docking Station CGM data sent to up to five followers smartphones Source: Close Concerns, Inc.
23 Animas Vibe with Dexcom G4 Platinum integration Under FDA review; potential launch in late 2014 Source: Close Concerns, Inc.
24 Tandem t:slim with Dexcom G4 Platinum integration Potential launch in late 2014/2015. Not yet submitted to FDA. Dual-chamber pump in development. Source: Close Concerns, Inc.
25 Medtronic MiniMed 640G (predictive suspend) European launch by October 31, 2014; no US timeline Predictive low glucose suspend much more effective than threshold suspend New pump platform and user interface New Enlite 2 CGM sensor Source: Close Concerns, Inc.
26 Outline About Us A snapshot of new and upcoming diabetes technology The bionic pancreas UVa s overnight closed-loop system The future of diabetes technology
27 A control algorithm running on an iphone
28 Two Tandem pumps + Dexcom G4 CGM
29 Dr. Ed Damiano (Boston University) Beacon Hill Study (amazing) 5 days of wear in 3 square-mile area Eat and exercise as wanted Average BG: 133 mg/dl, <1.5% <60 mg/dl Dr. Damiano s Timeline 2013: Beacon Hill, summer camp 2014: 12-day multi-center study 2014: Pre-adolescent summer camp ~2015/16: Pivotal study ~2017: Commercial launch Source: Close Concerns, Inc.
30 Amazing glucose control
31 I felt like a whole new Kelly
32 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
33 UVa s Overnight Closed-Loop System Five nights in a research house. Dexcom CGM, smartphone controller, Roche pump
34 UVa s Overnight Closed-Loop System CLOSED-LOOP ON The control algorithm adjusts insulin delivery from 11pm-7am to target 120 mg/dl
35 Some of my learnings Overnight closed-loop worked WAY better than I can do on my own, and was much safer My insulin requirements vary A LOT from night to night Diabetes disrupts sleep OFTEN! Great nighttime glucose control even improved my blood sugars the next day starting every morning at 120 mg/dl is pretty powerful.
36 Where Are We Right Now with the Closed Loop? 70%+ time in target during day Excellent overnight control (often 90%+) Outpatient trials Strong algorithms, constant improvement Remote monitoring and portable systems
37 A successful system looms large, but challenges aren t for the faint of heart Optimal device development/ communication Faster insulin / Stable glucagon (chronic use) Reimbursement Regulatory (FDA/EU) requirements/commerci alization
38 Artificial Pancreas: Fully Closed Loop/Dual Hormone Upside Guaranteed <7% A1c Huge patient demand Better reimbursement? Entry barriers Disruptive technology (opportunity to take market share) Roadblocks Unpredictable regulatory environment Speed of insulin (meals) Other hormones/ dual-chamber pump Reliability/safety of CGM Portability Slide 38
39 Other Artificial Pancreas systems: Hybrid Closed Loop Predictive low glucose suspend Predictive CGM trend forecasting Treat-to-range control Automated basal control (bolus at mealtime) Impact (primarily on type 1) More focus on time in zone Improvement in time in zone and likely A1c A decline in hypoglycemia and severe hypoglycemia Pumps/CGMs increasingly becoming standard of care in newly diagnosed type 1s Achievable meaningful increased quality of life Slide 39
40 Outline About Us A snapshot of new and upcoming diabetes technology The artificial pancreas UVa s overnight closed-loop system The future of diabetes technology
41 I look forward to a future where devices are more integrated into my daily life hypoglycemia and hyperglycemia are much less frequent better management doesn t mean more burden an d hassle I don t have to think about diabetes as much!
42 I look forward to a future where Devices are more integrated into my daily life Hypoglycemia and hyperglycemia are less frequent Better management doesn t mean more burden/hassle I don t have to think about diabetes as much! Slide 42
43 Slide 43
44 Sign up for our free patient newsletter at Write to give views to academia/industry THANK YOU JDRF GREATER C&P! Slide 44
45 THANK Slide 45
Alternative method for delivering insulin using continuous subcutaneous insulin infusion (CSII) open loop system
ISHP Spring CE Conference April 12, 2015 St. Luke s Medical Center Randi Lynn Griffiths, PharmD Clinical outpatient pharmacist Boise VA Medical Center Boise, Idaho Alternative method for delivering insulin
FDA Perspective on Closed-Loop Studies
FDA Perspective on Closed-Loop Studies Practical Ways to Achieve Targets in Diabetes Care July 19, 2014 Keystone, CO Courtney H. Lias, Ph.D. Office of In Vitro Diagnostic Device Evaluation and Safety Center
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy
Get Primed on Pumps: A beginners guide to Insulin Pump Therapy Advantages of insulin pump therapy There are many advantages to using an insulin pump. Anyone can do it with the right training and support.
US Diabetic Devices Industry Research Report: KenResearch
US Diabetic Devices Industry Research Report: KenResearch by KenResearch - Monday, February 24, 2014 https://www.kenresearch.com/blog/2014/02/us-diabetic-devices-industry-research-report-kenresearch/ The
Introducing DEXCOM STUDIO INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT
Introducing DEXCOM STUDIO Continuous Glucose Monitoring Software INTUITIVE. FOCUSED. SIMPLIFIED. HELP TAKE the GUESSWORK OUT of GLUCOSE PATTERN MANAGEMENT Glucose Pattern Management A Guide to Interpreting
The Future of Diabetes Old and New Working Together
The Future of Diabetes Old and New Working Together David L. Joffe, BSPharm, CDE, FACA Clinical Associate Professor Department of Pharmacotherapy & Translational Research, College of Pharmacy, University
Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner
Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers
Portfolio of Offerings
Portfolio of Offerings Byram Healthcare s One Source Total Solution provides extensive service and support to all those living with diabetes! We are a full service diabetes care provider offering all brand
Insulin Pump Management and Continuous Glucose Monitoring Systems (CGMS)
Insulin Pump Management and Continuous Glucose Monitoring Systems (CGMS) Faith Daily, RN, BSN, CDE, CPT Certified Diabetes Educator/Insulin Pump Trainer August 16, 2014 Why Pump Therapy? Mimics normal
Innovations in Diabetes. Angela Blair Channel Manager RN Credentialled Diabetes Educator
Innovations in Diabetes Angela Blair Channel Manager RN Credentialled Diabetes Educator Innovations Time - $$$ Innovations & Technology Blood Testing Insulin delivery devices Insulin pumps Pills & Potions
WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
4/7/2015 CONFLICT OF INTEREST DISCLOSURE OBJECTIVES. Conflicts of Interest None Heather Rush. Heather M. Rush, APRN, CDE Louisville, KY
Heather M. Rush, APRN, CDE Louisville, KY CONFLICT OF INTEREST DISCLOSURE Conflicts of Interest None Heather Rush A conflict of interest exists when an individual is in a position to profit directly or
The Basics of Insulin Pump Therapy
The Basics of Insulin Pump Therapy Table of Contents The Basics of Insulin Pump Therapy Introduction Welcome... 3 Chapter 1 Balancing Glucose and Insulin............................. 10 Section 1: Glucose,
Imagine a world... Believe in better control. MiniMed Veo Paradigm System Questions and Answers About Insulin Pumping
Imagine a world... Believe in better control MiniMed Veo Paradigm System Questions and Answers About Insulin Pumping 1 Imagine a world... Where you can exercise whenever you want and not have to carb load
Is what you know about INSULIN PUMP THERAPY. This educational resource is provided by Medtronic MiniMed, Inc.
Is what you know about INSULIN PUMP THERAPY MYTH or? This educational resource is provided by Medtronic MiniMed, Inc. You have to know a lot about technology to learn to use a pump Interacting with your
A guidebook for people with diabetes
A guidebook for people with diabetes This booklet is designed to supplement, not replace, your doctor s advice. Please consult your doctor if you have any questions about what you read. You ll learn how
Tidepool Informational Pre-submission Meeting
Tidepool Informational Pre-submission Meeting Prepared for FDA CDRH June 2, 2015 Tidepool attendees: Howard Look, President and CEO (phone) Brandon Arbiter, VP Product and BizDev (phone) Sheila Ramerman,
Introduction. We hope this guide will aide you and your staff in creating a safe and supportive environment for your students challenged by diabetes.
Introduction Diabetes is a chronic disease that affects the body s ability to metabolize food. The body converts much of the food we eat into glucose, the body s main source of energy. Glucose is carried
Diabetes and Technology. Disclosures Certified Insulin Pump Trainer for: Animas Medtronic Diabetes Omnipod. Rebecca Ray, MSN, APRN, FNP-C
Diabetes and Technology Rebecca Ray, MSN, APRN, FNP-C Insulin Pump Therapy and Continuous Glucose Monitoring In Patients with Type 2 Diabetes Page 1 Disclosures Certified Insulin Pump Trainer for: Animas
Smart Pumping with Insulin Pumps
Smart Pumping with Insulin Pumps Rita Ketay RN, CDE, Ed.M, BC-ADM Dartmouth Hitchcock Medical Center During this discussion we will: * Review the DCCT recommendations; * Define smart pumping ; * Discuss
Basal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes
Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE Insulin Pump Therapy Open looped system in which a small amount of insulin is continuously infused through a cannula or needle (basal rate) Larger doses
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
Diabetes Self Management Training Insulin Pump Follow Up
701 East Marshall Street, West Chester, PA 19380 www.chestercountyhospital.org 610.431.5000 Diabetes Self Management Training Insulin Pump Follow Up Patient Name: Visit Date: Time: To prepare for your
The Diabetes Self Management Insulin Pump Therapy Program
The Diabetes Self Management Insulin Pump Therapy Program Is part of a Nationally recognized program taught by CPT s Offers classes during the daytime in a three part series: PRE-PUMP CLASS SALINE START
Calculating Insulin Dose
Calculating Insulin Dose First, some basic things to know about insulin: Approximately 40-50% of the total daily insulin dose is to replace insulin overnight, when you are fasting and between meals. This
Basal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction)
Basal Rate Testing Blood sugar is affected at any time by 1) basal insulin 2) food (carbohydrate) intake 3) bolus insulin (meal time and correction) 4) activity and 5) other factors such as stress and
Activating Standardization Bodies Around Medical Apps
Activating Standardization Bodies Around Medical Apps Michael J. Ackerman, Ph.D. Assistant Director High Performance Computing and Communications U.S. National Library of Medicine The views and opinions
Taking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT
Taking Insulin Pumps to School Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT Insulin Pumps Today A micro-computer, about the size of a pager Programmed to deliver both a preset amount
3/14/2014. Objectives. What s New in Diabetes Care. Insulin. FlexTouch Pen (novo nordisk) Insulin Pen
Objectives What s New in Diabetes Care Expose you to new products designed to help you manage your diabetes Products mentioned were highlighted in Diabetes Forecast January 2014 issue Stacie Petersen,
The Quantified Self on Steroids: Innovation in Devices, Pumps and Monitors
The Quantified Self on Steroids: Innovation in Devices, Pumps and Monitors Howard A. Wolpert, MD 1 Diabetes is different to many other conditions Patient/Self Managed 2 To achieve the therapeutic goals
BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS
CHAPTER 6: BOLUS INSULIN DOSAGES H. Peter Chase, MD and Erin Cobry, BS WHAT IS BOLUS INSULIN? Bolus insulin dosages refer to the quick bursts of insulin given to cover the carbohydrates in meals or snacks
Tidepool FDA Pre-submission Draft Meeting Minutes
Tidepool FDA Pre-submission Draft Meeting Minutes October 14, 2014, 2:00pm EDT Food and Drug Administration, 10903 New Hampshire Ave., WO 66, Silver Spring, MD 20993 Pre submission Document ID: Pre submission
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES
Anneli, Martina s daughter In better control with her pump since 2011 MY CHILD HAS TYPE 1 DIABETES Many parents whose child is diagnosed with Type 1 diabetes wonder: Why is this happening to my child?
Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro
PRESS RELEASE Adocia reports positive results from phase IIa clinical study of ultra-fast acting BioChaperone Lispro BioChaperone Lispro is significantly faster than Humalog in type I diabetic patients;
Blood Glucose Management
Blood Glucose Management What Influences Blood Sugar Levels? There are three main things that influence your blood sugar: Nutrition Exercise Medication What Influences Blood Sugar Levels? NUTRITION 4 Meal
Diabetes Medications: Insulin Therapy
Diabetes Medications: Insulin Therapy Courtesy Univ Texas San Antonio Eric L. Johnson, M.D. Department of Family and Community Medicine Diabetes and Insulin Type 1 Diabetes Autoimmune destruction of beta
Type 1 Diabetes - Managing a Critical Ratio
Objectives Students will learn about how ratios and proportions are a key part of managing Type 1 Diabetes Students will learn about the regulation of blood glucose through insulin (hormone) binding with
Corporate Medical Policy
Corporate Medical Policy Continuous Monitoring of Glucose in the Interstitial Fluid File Name: Origination: Last CAP Review: Next CAP Review: Last Review: continuous_monitoring_of_glucose_in_the_interstitial_fluid
[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014
![[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014](/thumbs/31/14891700.jpg "[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014")
In adolescents with poorly controlled type 1 diabetes mellitus, could a bionic, bihormonal pancreas provide better blood glucose control than continuous subcutaneous insulin infusion therapy? [Frida Svendsen
Finally, the right fit for your insulin needs. www.tandemdiabetes.com
Finally, the right fit for your insulin needs. www.tandemdiabetes.com (Actual Size) For convenience and ease of use, the t:flex TM Insulin Pump just fits. It is designed to help make your day-to-day insulin
User Guide. Dashboard. Sam Smith Sign Out Born: 1/1/1980 Age:35. Apr 8-14, 2015. 4.57 times / day. 28.37 units / day.
User Guide DASHBOARD REPORTS Dashboard 3 Days 1 Week 2 Weeks 1 Month Custom My Notifications View: Unread Since your last upload: Reminder thresholds and settings have been changed. BG Summary Blood Glucose
Clinical Validity of Insulin Bolus Calculators
Clinical Validity of Insulin Bolus Calculators Howard A. Wolpert, MD Senior Physician, Joslin Diabetes Center Associate Professor, Harvard Medical School Director, Joslin Institute for Technology Translation
Medical Policy Insulin Pumps
Medical Policy Insulin Pumps Document Number: 027 Authorization required Insulin Pumps & supplies Notification within 24 hours of service or next business day No Prior Authorization Not covered Pulsatile
Medical Coverage Policy Glucose Monitoring Systems sad
Medical Coverage Policy Glucose Monitoring Systems sad EFFECTIVE DATE: 03 03 2009 POLICY LAST UPDATED: 01 17 2012 OVERVIEW This policy addresses several methods of monitoring blood glucose: the glucometer,
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus
Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus Louis Haenel, IV, DO, FACOI, FACE Endocrinology Roper Hospital Charleston, SC Dr. Louis Haenel IV has disclosed
Imagine a world... Believe in better control. MiniMed Veo Paradigm System
Imagine a world... Believe in better control MiniMed Veo Paradigm System 1 Imagine a world... Where you can exercise whenever you want and not have to carb load or worry about hypos. R Where you can eat
Insulin Pump Therapy. Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology
Insulin Pump Therapy Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology Disclosures Member of Clinical Advisory Panel for Tandem Work on a variety of clinical trials funded
Methods for Delivering Insulin and Monitoring Blood Sugar. A Review of the Research for Children, Teens, and Adults With Diabetes
Methods for Delivering Insulin and Monitoring Blood Sugar A Review of the Research for Children, Teens, and Adults With Diabetes Is This Information Right for Me? Yes, if: Your doctor* has told you that
EVALUATION OF AUTOMATIC CLASS III DESIGNATION FOR STUDIO on the Cloud Data Management Software DECISION SUMMARY
A. DEN Number: DEN140016 EVALUATION OF AUTOMATIC CLASS III DESIGNATION FOR STUDIO on the Cloud Data Management Software B. Purpose for Submission: DECISION SUMMARY De novo request for adjunct data management
I HAVE JUST BEEN DIAGNOSED WITH TYPE 1 DIABETES
Dominika In better control with her pump since 2012 I HAVE JUST BEEN DIAGNOSED WITH TYPE 1 DIABETES The diagnosis of Type 1 diabetes may come as a shock and may lead to many questions, such as: Why is
Health Professional s. Guide to INSULIN PUMP THERAPY
Health Professional s Guide to INSULIN PUMP THERAPY Table of Contents Introduction Presenting Insulin Pump Therapy to Your Patients When Your Patient Chooses the Pump Estimates for Starting Insulin Pump
Type 1 Diabetes - How the HHM System Evaluates Its Performance
511730DSTXXX10.1177/1932296813511730Journal of Diabetes Science and TechnologyFinan et al research-article2014 Original Article Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer
Algorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
AROC 2015. April 15, 2015. Edward R. Damiano, PhD. Professor Biomedical Engineering Boston University
G BIONIC AROC 2015 April 15, 2015 Edward R. Damiano, PhD Professor Biomedical Engineering Boston University This is the face of type 1 diabetes This is the face of type 1 diabetes This is the face of type
A Reference Guide for School Nurses. with the Medtronic MiniMed Insulin Pump
A Reference Guide for School Nurses with the Medtronic MiniMed Insulin Pump Table Of Contents I Table of Contents The Medtronic MiniMed Insulin Pump A Reference Guide for School Nurses For the 522, 722,
Type 1 Diabetes. Pennington Nutrition Series. Overview. About Insulin
Pennington Nutrition Series Healthier lives through education in nutrition and preventive medicine Pub No. 32 Type 1 Diabetes Overview Type 1 Diabetes (DM) is usually diagnosed in children and young adults.
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy
Insulin Dose Adjustment REAL-Time CGMS Guidelines for Subjects on Pump Therapy In addition to using the blood sugar logs to adjust your insulin doses every week, you should also use your continuous glucose
QUESTION 3. HOW SHOULD THE DATA AND REPORTING BE INTERPRETED?
QUESTION 3. HOW SHOULD THE DATA AND REPORTING BE INTERPRETED? AACE/ACE CGM Consensus Conference: Medical, Scientific, Professional, and Educational Societies Question 3a. Are there standard metrics that
Mobile App User Guide
Mobile App User Guide Contents 2 Contents Introduction... 4 OneTouch Reveal mobile app... 4 Supported Devices and System Requirements...4 Apple Legal Notice...4 Bluetooth Trademark...4 Intended Use...4
Gayle Curto, RN, BSN, CDE Clinical Coordinator
Gayle Curto, RN, BSN, CDE Clinical Coordinator INTRODUCTION Historical Program Overview Leadership Team Mission Statement Diabetes Center Demographics for 2011 Older Adult Population HISTORICAL PROGRAM
School Year 20 / 20. Diabetes Health Care Plan for Southgate Schools
School Year 20 / 20 Diabetes Health Care Plan for Southgate Schools Diabetes Medical Management Plan, Initialized Healthcare Plan and Physician Orders Part A: Contact Information must be completed by the
EVALUATION OF A BASAL-BOLUS INSULIN PROTOCOL FROM CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION IN NON-CRITICALLY ILL HOSPITALIZED PATIENTS
EVALUATION OF A BASAL-BOLUS INSULIN PROTOCOL FROM CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION IN NON-CRITICALLY ILL HOSPITALIZED PATIENTS Joanne Archer, MSN, APRN, BC-ADM, Maureen T. Greene, PhD,
Insulin/Diabetes Calculations
Insulin/Diabetes Calculations Dr. Aipoalani St Lukes Endocrinology Goals Describe various calculations for insulin dosing Understand importance of the total daily dose (TDD) of insulin Be able to calculate
Supplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Haidar A, Legault L, Matteau-Pelletier L, et
Section 504 Plan (pg 1 of 8)
Section 504 Plan (pg 1 of 8) of Birth School Today s Section 504 Plan for: Disability: Diabetes School Year: Grade: Homeroom Teacher: Bus Number: Background Objectives The student has type diabetes. Diabetes
BLOOD GLUCOSE MONITORING MEDICATION
DIABETES CARE FOR SCHOOL MEDICAL MANAGEMENT PLAN Most Recent A1C and Date: BLOOD GLUCOSE MONITORING Meter Type: Testing Independently: yes no Testing times: Before meals Two hours after insulin dosing
Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes
original article Outpatient Glycemic with a Bionic Pancreas in Type 1 Diabetes Steven J. Russell, M.D., Ph.D., Firas H. El-Khatib, Ph.D., Manasi Sinha, M.D., M.P.H., Kendra L. Magyar, M.S.N., N.P., Katherine
Your Insulin Adjustment Workbook Yes, You Can Do It!
S T AY I N G O N T A R G E T TARGET THERAPY Staying on Target TM Your Insulin Adjustment Workbook Yes, You Can Do It! YES, YOU CAN DO IT! Your How-To Guide for Adjusting Basal and Bolus Insulin This workbook
Policy #: 046 Latest Review Date: January 2015 Category: Durable Medical Equipment
Name of Policy: External Ambulatory Insulin Infusion Pump Policy #: 046 Latest Review Date: January 2015 Category: Durable Medical Equipment Policy Grade: A Background/Definitions: As a general rule, benefits
Design of an Insulin Pump. Purpose of an Insulin Pump:
Design of an Insulin Pump Purpose of an Insulin Pump: Insulin is a hormone central to regulating carbohydrate and fat metabolism in the body. It is secreted regularly within the body and aids in converting
WHAT I NEED TO KNOW ABOUT MY BLOOD SUGAR
WHAT I NEED TO KNOW ABOUT MY BLOOD SUGAR BLOOD WHAT I NEED SUGAR TO MANAGEMENT KNOW ABOUT GUIDE MY BLOOD SUGAR When you have type 2 diabetes, your body has a problem using the food you eat for energy.
The MiniMed Paradigm Veo System
The MiniMed Paradigm Veo System Live More, Worry Less First CGM-ready insulin pump with automatic insulin shut-off mechanism www.medtronic-diabetes.co.uk The freedom you deserve Round-the clock support
Feeling Better, Living Healthier With Diabetes
Feeling Better, Living Healthier With Diabetes A guide for self management 761 S. Nelson Ave. Wilmington, Ohio 45177 (937) 382-9307 www.cmhregional.com What is Diabetes? Those who have diabetes are often
How can the Internet of Things help in overcoming current challenges and make healthcare sustainable
How can the Internet of Things help in overcoming current challenges and make healthcare sustainable Davide Sola, ESCP Europe Jerome Couturier, ESCP Europe Giovanni Scarso Borioli, ESCP Europe Cristina
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS
BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS C O N T A C T D I A B E T E S S E R V I C E S F O R M O R E I N F O R M A T I O N 8 4 7-9 1 7-6 9 0 7 THIS SLIDE PRESENTATION WAS PREPARED BY SUE DROGOS,
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps Clinical Policy Number: 06.02.01 Effective Date: March 1, 2014 Initial Review Date: Nov. 20 th, 2013 Most Recent Review
Objectives. Clinical Impact of An Inpatient Diabetes Care Model. Impact of Diabetes on Hospitals. The Nebraska Medical Center Stats 6/5/2014
Objectives Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE Andjela Drincic, MD 1. Examine the development of the role of the diabetes case manager model in the inpatient setting
SCHOOL DISTRICT #22 VERNON DIABETES POLICY
SCHOOL DISTRICT #22 VERNON DIABETES POLICY A student with diabetes does not automatically qualify for additional support. The student may qualify as a temporary D category (chronic health) after diagnosis
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
Diabetes means you have too much sugar in
WHAT IS DIABETES? Diabetes means you have too much sugar in your blood. The medical word for sugar in the blood or blood sugar is glucose, but most people just say sugar. Your body changes most of the
Intensifying Insulin In Type 2 Diabetes
Intensifying Insulin In Type 2 Diabetes Eric L. Johnson, M.D. Associate Professor Department of Family and Community Medicine University of North Dakota School of Medicine and Health Sciences Assistant
Are you ready to pump?
The decision to use an insulin pump is not an easy one. There is a lot involved with managing diabetes using a pump. Take some time to make this decision. Talk about it with your family and your health
How to design an insulin pump
How to design an insulin pump Learn about the purpose of an insulin pump, its overall workings, and the requirements needed for its design as well as implementation. By Asha Ganesan Applications Engineer
Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?
Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? After eating, most food is turned into glucose, the body s main source of energy. 1 Normal Blood
Intelligent Insulin Pens
95 Intelligent Insulin Pens A promising technology toward smart diabetic management systems Mohammed Kalkattawi, Tatsuo Nakajima Department of Computer Science and Engineering Waseda University Japan,
Revolutionizing How Type 1 Diabetes Is Treated
HEALTH S e p t e m b e r 2 0 1 4 Revolutionizing How Type 1 Diabetes Is Treated Thirteen-year-old Louis Cocco one day hopes to become a professional hockey player, but at age two he was diagnosed with
Clinical Impact of An Inpatient Diabetes Care Model. Objectives
Clinical Impact of An Inpatient Diabetes Care Model Beth Pfeffer MSN, RN CDE June 4, 2014 Objectives 1. Examine the development of the role of the diabetes case manager model in the inpatient setting 2.
Causes, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
Insulin Initiation and Intensification
Insulin Initiation and Intensification ANDREW S. RHINEHART, MD, FACP, CDE MEDICAL DIRECTOR AND DIABETOLOGIST JOHNSTON MEMORIAL DIABETES CARE CENTER Objectives Understand the pharmacodynamics and pharmacokinetics
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care
The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care November 12, 2013 Caroline Isbey RN, MSN, CDE Associate Director Teresa Gomez Associate Project Director Specialist-SSM Carol
Getting the Big Picture
About Diabetes This health information is being provided for general educational purposes only. Your health care provider is the single best source of information regarding your health. Please consult
Managing Diabetes in the Athletic Population
Managing Diabetes in the Athletic Population Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson University Dedicated
Using Common Criteria Evaluations to Improve Healthcare Cybersecurity
Approved for Public Release; Distribution Unlimited. 15-2807 2015 The MITRE Corporation. ALL RIGHTS RESERVED. Using Common Criteria Evaluations to Improve Healthcare Cybersecurity David Kleidermacher Blackberry
Description. Comprehensive Education Courses Take Control Now! (2 Hour Session Billed to Insurance)
The University of Maryland Diabetes Network offers the latest available therapies, clinical trials and custom tailored care plans just for you. Education is a key component to living with and managing
Educational Objectives. Type 2 Diabetes: a progressive condition. Insulin Delivery Devices. Insulin we may wait too long
Educational Objectives Insulin Delivery Devices James Bennett RPh, FACA, CDE Director of Clinical Services at James Bennett Apothecary Corinth Mississippi After viewing this program, participants should
Get to know the Animas Vibe insulin pump and CGM * system.
Get to know the Animas Vibe insulin pump and CGM * system. * Continuous glucose monitoring with Animas Vibe is indicated for adult patients 18 years and older only. Hello. Get to know Animas. We make insulin
The Burden Of Diabetes And The Promise Of Biomedical Research
The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed
Glucose Monitoring in Interstitial Fluid Diabetes
Medical Coverage Policy Subject: Continuous Glucose Monitoring in Interstitial Fluid Policy #: MED Current Effective Date: 11/10/14 Status: New Last Review Date: 11/10/14 Description/Scope Tight glucose
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps
Clinical Policy Title: Disposable Continuous Subcutaneous Insulin Infusion Pumps Clinical Policy Number: 06.02.01 Effective Date: March 1, 2014 Initial Review Date: Nov. 20, 2013 Most Recent Review Date:
For people with diabetes. A blood sugar diary
For people with diabetes A blood sugar diary A circle of help to live a healthy life YOU are at the center of a healthy life with diabetes. All the elements of good care begin and end with YOU. The importance